Exposure to wild-type AAV drives distinct capsid immunity profiles in humans

Recombinant adeno-associated virus (AAV) vectors have been broadly adopted as a gene delivery tool in clinical trials, owing to their high efficiency of transduction of several host tissues and their low immunogenicity. However, a considerable proportion of the population is naturally exposed to the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Kuranda, Klaudia, Jean-Alphonse, Priscilla, Leborgne, Christian, Hardet, Romain, Collaud, Fanny, Marmier, Solenne, Costa Verdera, Helena, Ronzitti, Giuseppe, Veron, Philippe, Mingozzi, Federico
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6264647/
https://ncbi.nlm.nih.gov/pubmed/30352429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI122372
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller